Mandate
A Swiss research practice in life sciences, reserved for institutional principals.
[PLACEHOLDER mission paragraph 1] TILI publishes original sector coverage and conducts qualified-counterparty introductions in life sciences. The practice is Swiss-domiciled and operates within the FINMA perimeter applicable to non-regulated research activity. Engagements are intuitu personae and restricted to institutional principals, family offices, and strategic industrials.
[PLACEHOLDER mission paragraph 2] The mandate is deliberately narrow: TILI does not solicit retail counterparties, does not handle client funds, and does not provide regulated investment advice. What it does provide is rigorous sector research, structured introductions among qualified principals, and targeted diligence support — under terms set per engagement, never productized.
Scope of activities.
[PLACEHOLDER scope paragraph 1] Original research on life-sciences deal flow, mechanism-class taxonomies, and competitive landscapes — published illustratively, with engagement-specific work shared only with the relevant counterparty.
[PLACEHOLDER scope paragraph 2] Qualified-counterparty introductions among institutional principals, family offices, strategic industrials, and biotech management — on an intuitu personae basis, with the originating relationship made transparent to all parties.
[PLACEHOLDER scope paragraph 3] Diligence support across scientific review, transaction-comparable benchmarking, and mechanism-class triangulation — scoped per engagement, retained by the principal, never resold.
What we do not do.
[PLACEHOLDER — this is the FINMA-defensive surface; final language must mirror the care of Onward Articles 3.2 / 4.1.d / 14.3] No solicitation of retail or non-qualified counterparties, in any jurisdiction. The practice does not market to, or transact with, persons outside the qualified-investor definitions of the relevant Swiss and counterpart-jurisdiction regimes.
[PLACEHOLDER] No handling of client funds, no custody, no payment intermediation. TILI does not receive, hold, or transmit assets on behalf of any party, and is not authorized to do so.
[PLACEHOLDER] No regulated investment advice within the meaning of FinSA / MiFID II. Public research is illustrative, not a recommendation; it is not directed at any specific person and does not constitute a basis for investment decisions.
Sector
[PLACEHOLDER pull quote] "The sector rewards specificity. Our coverage is narrow by design — and deeper for it."